With more than 10 years of experience in the automotive industry, managing global projects and leading a global project management team, Tobias Porth has a rich background in handling complex, international initiatives. For the past year, he has brought his expertise to Boehringer Ingelheim's Animal Health business unit, where he serves as an Engineering Network Manager, playing a key role in Global Capex Management.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.